Select a State

Global health R&D delivers for California

US government investment in global health R&D has delivered

$876.4 million
to California research institutions
11,800+ new jobs
for California
4453

Neglected diseases in California

Chikungunya cases
496
Dengue cases
689
HIV diagnoses
46321
Malaria cases
859
Tuberculosis cases
20484
West Nile cases
3710
Zika cases
480

California

--

California's top USG-funded global health R&D institutions

The Scripps Research Institute
$ 189.5 million
University of California, San Francisco
$ 151.2 million
University of California, Los Angeles (including Los Angeles Biomedical Research Institute at Harbor – UCLA Medical Center)
$ 60.4 million
University of California, Davis (including Regents of the University of California, Davis)
$ 56.7 million
University of California, Irvine
$ 55.7 million
University of California, San Diego (including Regents of the University of California, San Diego)
$ 53 million
SRI International
$ 52.4 million
University of California, Berkeley
$ 50.4 million
Stanford University (including the Center for Innovations in Global Health)
$ 44.5 million
La Jolla Institute for Allergy and Immunology
$ 18.1 million

California industry in global health R&D

AbbVie
Location(s):
Redwood City, San Francisco
Acea Biotech
Location(s):
San Francisco
Actelion
Location(s):
South San Francisco
Ajinomoto Althea
Location(s):
San Diego
Alere
Location(s):
San Diego
Amgen
Location(s):
South San Francisco, Thousand Oaks
Astellas
Location(s):
Menlo Park, San Diego
AstraZeneca
Location(s):
South San Francisco
Bayer
Location(s):
Berkley, San Francisco, West Sacramento
Beckman Coulter
Location(s):
Brea
item[company]
Location(s):
Redwood City
item[company]
Location(s):
San Diego, San Francisco
item[company]
Location(s):
Inglewood
item[company]
Location(s):
Sunnyvale
item[company]
Location(s):
Hollister, San Diego, South San Francisco
item[company]
Location(s):
San Diego
item[company]
Location(s):
San Diego
item[company]
Location(s):
Foster City, La Verne, Oceanside, San Dimas
item[company]
Location(s):
San Diego
item[company]
Location(s):
San Diego
item[company]
Location(s):
San Diego
item[company]
Location(s):
Redwood City, San Diego
item[company]
Location(s):
La Jolla
item[company]
Location(s):
San Diego, South San Francisco
item[company]
Location(s):
San Diego
item[company]
Location(s):
Los Angeles
item[company]
Location(s):
Carlsbad, Emeryville, Irvine, Lake Forest, San Carlos, San Diego
item[company]
Location(s):
Palo Alto
item[company]
Location(s):
Redwood City, San Diego
item[company]
Location(s):
San Diego
item[company]
Location(s):
La Jolla
item[company]
Location(s):
San Diego
item[company]
Location(s):
Redwood City, Valencia
item[company]
Location(s):
Pleasanton
item[company]
Location(s):
San Francisco

California's top areas of global health R&D by USG funding

30.2%
HIV/AIDS
16.3%
Malaria
17%
Tuberculosis
2.8%
Diarrheal diseases
4.2%
Salmonella infections
16.9%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
Leprosy
Trachoma
12.5%
Other
Bacteria pneumonia & meningitis
Cryptococcal meningitis
Ebola/viral hemorrhagic fevers
Hepatitis C
Non-allocable
Rheumatic fever

Global health R&D at work in California

Using a method developed at the University of California-San Francisco, Stanford University researchers have created a compound, still in early stages, that combats drug-resistant malaria parasites without harm to human cells. Despite global efforts, malaria infects nearly 200 million people each year, mostly in Africa and Asia, and kills more than 400,000—primarily children under five. Scientists are racing to find new treatments before current drugs stop working.

Footnotes